US Stocks
/
Aprea Therapeutics, Inc. Common stock Share Price
Aprea Therapeutics, Inc. Common stock Share Price

Aprea Therapeutics, Inc. Common stock Share Price

NASDAQ: APRE
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Aprea Therapeutics, Inc. Common stock Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Aprea Therapeutics, Inc. Common stock Share Price Chart

$0.00$0.00
L
Show Current Price
H

Aprea Therapeutics, Inc. Common stock Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
$-1.93
Revenue (TTM)
$285759.00
Return On Equity (TTM)
-101.27%
Profit Margin
-4409.16%
Debt to Equity
0.22
Quarterly Earnings Growth YoY
21.44%

Aprea Therapeutics, Inc. Common stock Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/A$561574.00$354621.00$162463.00$118111.00$1848.00
Net Profit-$2.81M-$3.47M-$3.78M-$3.93M-$3.24M-$2.97M
Net Profit MarginN/A-617.92%-1066.99%-2420.65%-2742.23%-160844.70%
Income ChangeN/A-23.49%-9.04%-3.93%17.64%8.23%

Aprea Therapeutics, Inc. Common stock Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$583231.00$1.50M$285759.00
Net Profit-$14.29M-$12.96M-$12.60M
Net Profit Margin-2449.59%-862.43%-4409.16%
Income ChangeN/A9.30%2.77%

About Aprea Therapeutics, Inc. Common stock

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumors with biomarkers; and ATRN-119, an ATR inhibitor, which is in Phase 1/2a clinical trial for solid tumor indications. The company is headquartered in Doylestown, Pennsylvania.

Aprea Therapeutics, Inc. Common stock Historical Returns

MonthOpenCloseChange %

APRE Share Price FAQs

What is Aprea Therapeutics, Inc. Common stock share price today?

chevron-up
Aprea Therapeutics, Inc. Common stock share price today is $0.00 as on August 9, 2026 at 11:11 am IST.

What is the 52 week high and 52 week low of Aprea Therapeutics, Inc. Common stock stock?

chevron-up
52 week high/low data for Aprea Therapeutics, Inc. Common stock is currently unavailable.

What is APRE's net income for the last quarter?

chevron-up
APRE's net income for the last quarter is -0.00B USD.

Can I buy APRE shares in India?

chevron-up
Yes. You can buy APRE in India by opening an international trading account.